SCHEMBL8911310

SCHEMBL8911310

Nc1c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA12 O43570 3/20 0.32
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
CA14 Q9ULX7 3/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 2/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
CA3 P07451 2/20 0.31
CA4 P22748 2/20 0.31
CA6 P23280 2/20 0.31
CA5A P35218 2/20 0.31
CA7 P43166 2/20 0.31
CA13 Q8N1Q1 2/20 0.31
CA5B Q9Y2D0 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11381319 0.93 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10L3MBTL1CA12
SCHEMBL11178469 0.91 ALDH1A1 (0.36) ALDH1A1KDM4EHSD17B10L3MBTL1LMNA
SCHEMBL11522523 0.90 HTT (0.40) ALDH1A1KDM4EHSD17B10L3MBTL1CA12
SCHEMBL10621991 0.90 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10L3MBTL1CA12
SCHEMBL9787562 0.88 ALDH1A1 (0.36) ALDH1A1KDM4EHSD17B10L3MBTL1CA12
SCHEMBL11172819 0.83 BRD4 (0.35) ALDH1A1KDM4EHSD17B10L3MBTL1LMNA
SCHEMBL6864271 0.83 HTT (0.40) ALDH1A1KDM4EHSD17B10L3MBTL1CA12
SCHEMBL11170960 0.83 HPGD (0.43) ALDH1A1KDM4EHSD17B10CA12CA1
SCHEMBL11120118 0.81 LMNA (0.35) ALDH1A1KDM4EHSD17B10L3MBTL1LMNA
SCHEMBL11694667 0.81 APEX1 (0.43) ALDH1A1KDM4EL3MBTL1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100344606-C Iodine Ioxilan preparation method JIANGSU INST OF NUCLEAR MED (CN) 2007-10-24 CN disclosed
US-5609851-A Compounds which can be used in contrast products for radiography GUERBET S A. (FR) 1997-03-11 US disclosed
EP-0619744-A4 NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS. MALLINCKRODT MEDICAL INC (US) 1995-02-08 EP disclosed
EP-0619744-A1 NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS MALLINCKRODT MEDICAL, INC. (US) 1994-10-19 EP disclosed
WO-1994005337-A1 NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS MALLINCKRODT MEDICAL, INC. (US) 1994-03-17 WO disclosed
EP-0308364-B1 Dicarboxylic acid-bis(3,5-dicarbamoyl-2-4-6-triiodanilides), process for their preparation and X-ray contrast agents containing them SCHERING AG (DE) 1993-11-10 EP disclosed
US-5232685-A Administering the 5-hydroxyacetamido-triido-isophthalic acid diamide for electroradiography SCHERING AKTIENGESELLSCHAFT (DE) 1993-08-03 US disclosed
WO-1993010825-A1 NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS MALLINCKRODT MEDICAL, INC. (US) 1993-06-10 WO disclosed
US-5191120-A Process for preparing nonionic X-ray contrast agents MALLINCKRODT MEDICAL, INC. (US) 1993-03-02 US disclosed
US-5183654-A 5-hydroxyacetamido-2,4,6-tiiodo-isophthalic acid-(2,3-dihydroxy-N-methyl-propyl)-(2-hydroxy-ethyl)-diamide; suitable for accurate diagnosis SCHERING AKTIENGESELLSCHAFT (DE) 1993-02-02 US disclosed
EP-0504266-A1 NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS MALLINCKRODT, INC. (US) 1992-09-23 EP disclosed
US-5075502-A NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS MALLINCKRODT, INC. (US) 1991-12-24 US disclosed
WO-1991009007-A2 NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS MALLINCKRODT, INC. (US) 1991-06-27 WO disclosed
US-4132731-A X-RAY CONTRAST AGENT SCHERING AKTIENGESELLSCHAFT (DE) 1979-01-02 US disclosed